Vivos Therapeutics Advances South Florida Sleep Center With South Palm Cardiovascular Partnership
Vivos Therapeutics (VVOS) partners with South Palm Cardiovascular Associates to establish a Sleep & Airway Medicine Center in Florida. Vivos will hold 75% of the new entity, AIM Florida, with plans to start operations in Q1 2027. The center aims to treat 250 patients monthly, generating up to $6M annual revenue with 30%+ margins. SPCVA will expand referrals for sleep disorder-related conditions. VVOS stock is currently at $0.25, up 0.58%.
How this was made
The 30-second read
Why it matters
The agreement introduces a new clinic model that could diversify Vivos' revenue base, though the financial impact is modest relative to the company's market cap.
Market read
First disclosure of a partnership that adds a new revenue line for a micro‑cap, with limited immediate market impact.
What to watch
Potential dependence on referral volume from SPCVA and the need for successful payer enrollment.
Background
Vivos Therapeutics (VVOS) focuses on devices for obstructive sleep apnea. The collaboration with South Palm Cardiovascular aims to create a physician‑aligned management services organization.
Ticker impact
Vivos Therapeutics announced a definitive collaboration with South Palm Cardiovascular to launch a Sleep & Airway Medicine Center, projecting up to $6 million annual revenue.
Modest upside pressure as investors price in the $6 M revenue outlook.
The deal is the first disclosed partnership for Vivos and adds a tangible revenue source, but the scale is limited for a micro‑cap.
Market effects
May signal growing demand for integrated sleep‑apnea services within cardiovascular care.
Adds a new specialty clinic in South Florida, modest local healthcare market effect.
Limited to niche medical‑device segment; unlikely to affect broader markets.
Counterpoint
The projected $6 M revenue is modest and may be delayed by regulatory or payer hurdles, limiting upside.
Key entities
- companyVivos Therapeutics, Inc.
Medical device and healthcare services firm developing sleep‑apnea solutions.
- companySouth Palm Cardiovascular Associates
Physician‑owned cardiology practice partnering with Vivos.
